Cargando…
Reduced expression of DACT2 promotes hepatocellular carcinoma progression: involvement of methylation-mediated gene silencing
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most aggressive malignancies in humans, and its prognosis is generally poor even after surgery. Many advances have been made to understand the pathogenesis of HCC; however, the molecular mechanisms that lead to hepatocarcinogenesis and progres...
Autores principales: | Gao, Sheng, Yang, Zhe, Zheng, Zhi-Yun, Yao, Jia, Zhang, Feng, Wu, Li-Ming, Xie, Hai-Yang, zhou, Lin, Zheng, Shu-Sen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605395/ https://www.ncbi.nlm.nih.gov/pubmed/23496880 http://dx.doi.org/10.1186/1477-7819-11-57 |
Ejemplares similares
-
Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma
por: Guo, Yan-li, et al.
Publicado: (2017) -
Effects of DACT1 methylation status on invasion and metastasis of nasopharyngeal carcinoma
por: Yang, Ju-Hong, et al.
Publicado: (2019) -
Methylation of DACT2 promotes breast cancer development by activating Wnt signaling
por: Li, Jingyi, et al.
Publicado: (2017) -
The Role of DACT Family Members in Tumorigenesis and Tumor Progression
por: Zeng, Yu, et al.
Publicado: (2022) -
Downregulation of DACT-2 by Promoter Methylation and its Clinicopathological Significance in Prostate Cancer
por: Li, Shibao, et al.
Publicado: (2019)